RNA5SP282

Across TCGA pan-cancer cohorts, RNA5SP282 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNA5SP282’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RNA5SP282 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP282 is over-expressed in tumor.

LUAD, BRCA, and PAAD are the cancer types where RNA5SP282 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNA5SP282 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.511	.006	6	view →
BRCA	All	All	+0.221	.022	4	view →
PAAD	Female	All	+1.400	.032	2	view →
KIRC	Male	All	+0.115	.010	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RNA5SP282–LUAD

Open the LUAD breakdown →